HEADER OXIDOREDUCTASE 31-DEC-15 5FS8 TITLE CRYSTAL STRUCTURE OF THE G308E MUTANT OF HUMAN APOPTOSIS INDUCING TITLE 2 FACTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS-INDUCING FACTOR 1, MITOCHONDRIAL; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 103-613; COMPND 5 SYNONYM: PROGRAMMED CELL DEATH PROTEIN 8, APOPTOSIS INDUCING FACTOR; COMPND 6 EC: 1.1.1.-; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: ADDITIONAL C-TERMINAL RESIDUES L614-V615-P616-R617 ARE COMPND 10 PART OF THE THROMBIN SITE. RESIDUES 104-124,546-558 AND 612-617 ARE COMPND 11 DISORDERED SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PKK233-3 KEYWDS MITOCHONDRIA, FLAVOPROTEIN, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR I.SEVRIOUKOVA REVDAT 5 10-JAN-24 5FS8 1 REMARK REVDAT 4 28-SEP-16 5FS8 1 JRNL REVDAT 3 25-MAY-16 5FS8 1 JRNL REVDAT 2 18-MAY-16 5FS8 1 JRNL REVDAT 1 11-MAY-16 5FS8 0 JRNL AUTH I.SEVRIOUKOVA JRNL TITL STRUCTURE/FUNCTION RELATIONS IN AIFM1 VARIANTS ASSOCIATED JRNL TITL 2 WITH NEURODEGENERATIVE DISORDERS JRNL REF J.MOL.BIOL. V. 428 3650 2016 JRNL REFN ISSN 0022-2836 JRNL PMID 27178839 JRNL DOI 10.1016/J.JMB.2016.05.004 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 89.75 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 97342 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.192 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5075 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6235 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.3220 REMARK 3 BIN FREE R VALUE SET COUNT : 308 REMARK 3 BIN FREE R VALUE : 0.3510 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3665 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 644 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.09000 REMARK 3 B22 (A**2) : 0.55000 REMARK 3 B33 (A**2) : -1.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.41000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.057 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.060 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.045 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.340 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.975 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.964 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4044 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3957 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5523 ; 1.541 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9145 ; 0.783 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 535 ; 5.829 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 177 ;32.201 ;23.277 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 726 ;12.343 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 37 ;19.351 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 611 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4617 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 929 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1988 ; 1.216 ; 1.419 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1987 ; 1.216 ; 1.418 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2506 ; 1.997 ; 2.123 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2056 ; 1.641 ; 1.644 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2991 ; 2.663 ; 2.376 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 125 A 1000 REMARK 3 ORIGIN FOR THE GROUP (A): -5.5970 4.2170 -29.5551 REMARK 3 T TENSOR REMARK 3 T11: 0.0064 T22: 0.0042 REMARK 3 T33: 0.0571 T12: 0.0015 REMARK 3 T13: -0.0112 T23: -0.0026 REMARK 3 L TENSOR REMARK 3 L11: 0.3256 L22: 0.3593 REMARK 3 L33: 0.9230 L12: 0.1216 REMARK 3 L13: -0.0594 L23: 0.0004 REMARK 3 S TENSOR REMARK 3 S11: -0.0114 S12: 0.0043 S13: -0.0050 REMARK 3 S21: 0.0221 S22: 0.0293 S23: 0.0081 REMARK 3 S31: 0.0410 S32: -0.0347 S33: -0.0179 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 5FS8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-DEC-15. REMARK 100 THE DEPOSITION ID IS D_1290065917. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 102452 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 37.170 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.62000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1M6I REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM ACETATE AND 20% POLY REMARK 280 -ETHYLENE GLYCOL, PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.87500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 103 REMARK 465 LEU A 104 REMARK 465 THR A 105 REMARK 465 PRO A 106 REMARK 465 GLU A 107 REMARK 465 GLN A 108 REMARK 465 LYS A 109 REMARK 465 GLN A 110 REMARK 465 LYS A 111 REMARK 465 LYS A 112 REMARK 465 ALA A 113 REMARK 465 ALA A 114 REMARK 465 LEU A 115 REMARK 465 SER A 116 REMARK 465 ALA A 117 REMARK 465 SER A 118 REMARK 465 GLU A 119 REMARK 465 GLY A 120 REMARK 465 GLU A 121 REMARK 465 GLU A 122 REMARK 465 VAL A 123 REMARK 465 PRO A 124 REMARK 465 SER A 546 REMARK 465 THR A 547 REMARK 465 PRO A 548 REMARK 465 ALA A 549 REMARK 465 VAL A 550 REMARK 465 PRO A 551 REMARK 465 GLN A 552 REMARK 465 ALA A 553 REMARK 465 PRO A 554 REMARK 465 VAL A 555 REMARK 465 GLN A 556 REMARK 465 GLY A 557 REMARK 465 GLU A 558 REMARK 465 GLU A 612 REMARK 465 ASP A 613 REMARK 465 LEU A 614 REMARK 465 VAL A 615 REMARK 465 PRO A 616 REMARK 465 ARG A 617 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN A 403 O HOH A 2234 1.71 REMARK 500 OG1 THR A 263 ND2 ASN A 403 1.74 REMARK 500 NH2 ARG A 358 O HOH A 2390 1.89 REMARK 500 O HOH A 2346 O HOH A 2347 1.92 REMARK 500 O HOH A 2319 O HOH A 2327 2.04 REMARK 500 OE2 GLU A 167 O HOH A 2048 2.05 REMARK 500 OE1 GLU A 308 O HOH A 2339 2.07 REMARK 500 O HOH A 2365 O HOH A 2370 2.08 REMARK 500 OE1 GLU A 167 OH TYR A 204 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 285 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 177 -105.40 -132.61 REMARK 500 ASN A 186 30.09 -92.14 REMARK 500 ARG A 285 -51.09 -140.49 REMARK 500 SER A 376 59.84 34.14 REMARK 500 LEU A 486 77.54 -107.72 REMARK 500 THR A 534 170.25 71.52 REMARK 500 ILE A 541 56.76 -141.01 REMARK 500 LYS A 571 -3.60 77.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2196 DISTANCE = 5.93 ANGSTROMS REMARK 525 HOH A2205 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH A2272 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH A2280 DISTANCE = 6.00 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 1000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FS6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE V243L MUTANT OF HUMAN APOPTOSIS INDUCING REMARK 900 FACTOR REMARK 900 RELATED ID: 5FS7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE G262S MUTANT OF HUMAN APOPTOSIS INDUCING REMARK 900 FACTOR REMARK 900 RELATED ID: 5FS9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE G338E MUTANT OF HUMAN APOPTOSIS INDUCING REMARK 900 FACTOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 G308E MUTATION AND ADDITIONAL L614-V615-P616-R617 RESIDUES REMARK 999 AT THE C-TERMINUS DBREF 5FS8 A 103 613 UNP O95831 AIFM1_HUMAN 103 613 SEQADV 5FS8 LEU A 614 UNP O95831 EXPRESSION TAG SEQADV 5FS8 VAL A 615 UNP O95831 EXPRESSION TAG SEQADV 5FS8 PRO A 616 UNP O95831 EXPRESSION TAG SEQADV 5FS8 ARG A 617 UNP O95831 EXPRESSION TAG SEQADV 5FS8 GLU A 308 UNP O95831 GLY 308 ENGINEERED MUTATION SEQRES 1 A 515 GLY LEU THR PRO GLU GLN LYS GLN LYS LYS ALA ALA LEU SEQRES 2 A 515 SER ALA SER GLU GLY GLU GLU VAL PRO GLN ASP LYS ALA SEQRES 3 A 515 PRO SER HIS VAL PRO PHE LEU LEU ILE GLY GLY GLY THR SEQRES 4 A 515 ALA ALA PHE ALA ALA ALA ARG SER ILE ARG ALA ARG ASP SEQRES 5 A 515 PRO GLY ALA ARG VAL LEU ILE VAL SER GLU ASP PRO GLU SEQRES 6 A 515 LEU PRO TYR MET ARG PRO PRO LEU SER LYS GLU LEU TRP SEQRES 7 A 515 PHE SER ASP ASP PRO ASN VAL THR LYS THR LEU ARG PHE SEQRES 8 A 515 LYS GLN TRP ASN GLY LYS GLU ARG SER ILE TYR PHE GLN SEQRES 9 A 515 PRO PRO SER PHE TYR VAL SER ALA GLN ASP LEU PRO HIS SEQRES 10 A 515 ILE GLU ASN GLY GLY VAL ALA VAL LEU THR GLY LYS LYS SEQRES 11 A 515 VAL VAL GLN LEU ASP VAL ARG ASP ASN MET VAL LYS LEU SEQRES 12 A 515 ASN ASP GLY SER GLN ILE THR TYR GLU LYS CYS LEU ILE SEQRES 13 A 515 ALA THR GLY GLY THR PRO ARG SER LEU SER ALA ILE ASP SEQRES 14 A 515 ARG ALA GLY ALA GLU VAL LYS SER ARG THR THR LEU PHE SEQRES 15 A 515 ARG LYS ILE GLY ASP PHE ARG SER LEU GLU LYS ILE SER SEQRES 16 A 515 ARG GLU VAL LYS SER ILE THR ILE ILE GLY GLU GLY PHE SEQRES 17 A 515 LEU GLY SER GLU LEU ALA CYS ALA LEU GLY ARG LYS ALA SEQRES 18 A 515 ARG ALA LEU GLY THR GLU VAL ILE GLN LEU PHE PRO GLU SEQRES 19 A 515 LYS GLY ASN MET GLY LYS ILE LEU PRO GLU TYR LEU SER SEQRES 20 A 515 ASN TRP THR MET GLU LYS VAL ARG ARG GLU GLY VAL LYS SEQRES 21 A 515 VAL MET PRO ASN ALA ILE VAL GLN SER VAL GLY VAL SER SEQRES 22 A 515 SER GLY LYS LEU LEU ILE LYS LEU LYS ASP GLY ARG LYS SEQRES 23 A 515 VAL GLU THR ASP HIS ILE VAL ALA ALA VAL GLY LEU GLU SEQRES 24 A 515 PRO ASN VAL GLU LEU ALA LYS THR GLY GLY LEU GLU ILE SEQRES 25 A 515 ASP SER ASP PHE GLY GLY PHE ARG VAL ASN ALA GLU LEU SEQRES 26 A 515 GLN ALA ARG SER ASN ILE TRP VAL ALA GLY ASP ALA ALA SEQRES 27 A 515 CYS PHE TYR ASP ILE LYS LEU GLY ARG ARG ARG VAL GLU SEQRES 28 A 515 HIS HIS ASP HIS ALA VAL VAL SER GLY ARG LEU ALA GLY SEQRES 29 A 515 GLU ASN MET THR GLY ALA ALA LYS PRO TYR TRP HIS GLN SEQRES 30 A 515 SER MET PHE TRP SER ASP LEU GLY PRO ASP VAL GLY TYR SEQRES 31 A 515 GLU ALA ILE GLY LEU VAL ASP SER SER LEU PRO THR VAL SEQRES 32 A 515 GLY VAL PHE ALA LYS ALA THR ALA GLN ASP ASN PRO LYS SEQRES 33 A 515 SER ALA THR GLU GLN SER GLY THR GLY ILE ARG SER GLU SEQRES 34 A 515 SER GLU THR GLU SER ARG ALA SER GLU ILE THR ILE PRO SEQRES 35 A 515 PRO SER THR PRO ALA VAL PRO GLN ALA PRO VAL GLN GLY SEQRES 36 A 515 GLU ASP TYR GLY LYS GLY VAL ILE PHE TYR LEU ARG ASP SEQRES 37 A 515 LYS VAL VAL VAL GLY ILE VAL LEU TRP ASN ILE PHE ASN SEQRES 38 A 515 ARG MET PRO ILE ALA ARG LYS ILE ILE LYS ASP GLY GLU SEQRES 39 A 515 GLN HIS GLU ASP LEU ASN GLU VAL ALA LYS LEU PHE ASN SEQRES 40 A 515 ILE HIS GLU ASP LEU VAL PRO ARG HET FAD A1000 53 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE FORMUL 2 FAD C27 H33 N9 O15 P2 FORMUL 3 HOH *644(H2 O) HELIX 1 1 GLY A 140 ASP A 154 1 15 HELIX 2 2 ARG A 172 LYS A 177 5 6 HELIX 3 3 LYS A 177 PHE A 181 5 5 HELIX 4 4 ASN A 186 LEU A 191 1 6 HELIX 5 5 PRO A 207 TYR A 211 5 5 HELIX 6 6 LEU A 267 ARG A 272 1 6 HELIX 7 7 GLY A 274 ARG A 280 1 7 HELIX 8 8 LYS A 286 VAL A 300 1 15 HELIX 9 9 GLY A 309 GLY A 327 1 19 HELIX 10 10 PRO A 345 GLU A 359 1 15 HELIX 11 11 LEU A 406 GLY A 411 1 6 HELIX 12 12 HIS A 454 MET A 469 1 16 HELIX 13 13 ASN A 516 GLY A 525 1 10 HELIX 14 14 ILE A 528 THR A 534 1 7 HELIX 15 15 ARG A 584 GLY A 595 1 12 HELIX 16 16 ASP A 600 LYS A 606 1 7 HELIX 17 17 LEU A 607 ASN A 609 5 3 SHEET 1 AA 6 GLY A 224 LEU A 228 0 SHEET 2 AA 6 ARG A 158 VAL A 162 1 O VAL A 159 N ALA A 226 SHEET 3 AA 6 HIS A 131 ILE A 137 1 O PHE A 134 N LEU A 160 SHEET 4 AA 6 GLN A 250 ILE A 258 1 O THR A 252 N VAL A 132 SHEET 5 AA 6 ILE A 433 VAL A 435 1 O TRP A 434 N ILE A 258 SHEET 6 AA 6 GLN A 428 ARG A 430 -1 N ALA A 429 O ILE A 433 SHEET 1 AB 6 GLY A 224 LEU A 228 0 SHEET 2 AB 6 ARG A 158 VAL A 162 1 O VAL A 159 N ALA A 226 SHEET 3 AB 6 HIS A 131 ILE A 137 1 O PHE A 134 N LEU A 160 SHEET 4 AB 6 GLN A 250 ILE A 258 1 O THR A 252 N VAL A 132 SHEET 5 AB 6 MET A 242 LEU A 245 -1 O VAL A 243 N ILE A 251 SHEET 6 AB 6 VAL A 233 ASP A 237 1 N VAL A 234 O LYS A 244 SHEET 1 AC 2 ARG A 192 LYS A 194 0 SHEET 2 AC 2 GLU A 200 SER A 202 -1 O ARG A 201 N PHE A 193 SHEET 1 AD 2 GLY A 262 PRO A 264 0 SHEET 2 AD 2 LEU A 400 PRO A 402 -1 O GLU A 401 N THR A 263 SHEET 1 AE 5 THR A 281 LEU A 283 0 SHEET 2 AE 5 HIS A 393 ALA A 396 1 O ILE A 394 N THR A 282 SHEET 3 AE 5 SER A 302 ILE A 306 1 O THR A 304 N VAL A 395 SHEET 4 AE 5 GLU A 329 LEU A 333 1 O GLU A 329 N ILE A 303 SHEET 5 AE 5 LYS A 362 MET A 364 1 O LYS A 362 N GLN A 332 SHEET 1 AF 3 VAL A 369 SER A 375 0 SHEET 2 AF 3 LYS A 378 LEU A 383 -1 O LYS A 378 N SER A 375 SHEET 3 AF 3 LYS A 388 THR A 391 -1 O VAL A 389 N ILE A 381 SHEET 1 AG 3 PHE A 421 ARG A 422 0 SHEET 2 AG 3 ALA A 440 ASP A 444 1 N CYS A 441 O PHE A 421 SHEET 3 AG 3 GLY A 448 ARG A 450 -1 O GLY A 448 N ASP A 444 SHEET 1 AH 5 MET A 481 ASP A 485 0 SHEET 2 AH 5 GLY A 491 GLY A 496 -1 O TYR A 492 N SER A 484 SHEET 3 AH 5 VAL A 572 TRP A 579 -1 O ILE A 576 N ILE A 495 SHEET 4 AH 5 LYS A 562 ARG A 569 -1 O GLY A 563 N TRP A 579 SHEET 5 AH 5 THR A 504 ALA A 509 -1 O VAL A 505 N PHE A 566 SITE 1 AC1 40 GLY A 138 GLY A 139 GLY A 140 THR A 141 SITE 2 AC1 40 ALA A 142 VAL A 162 GLU A 164 ASP A 165 SITE 3 AC1 40 ARG A 172 PRO A 173 SER A 176 LYS A 177 SITE 4 AC1 40 LYS A 231 LYS A 232 VAL A 233 ALA A 259 SITE 5 AC1 40 THR A 260 GLY A 261 ARG A 285 LYS A 286 SITE 6 AC1 40 ASN A 403 GLY A 437 ASP A 438 GLU A 453 SITE 7 AC1 40 HIS A 454 HIS A 455 ALA A 458 PHE A 482 SITE 8 AC1 40 TRP A 483 HOH A2013 HOH A2016 HOH A2017 SITE 9 AC1 40 HOH A2019 HOH A2058 HOH A2233 HOH A2237 SITE 10 AC1 40 HOH A2304 HOH A2350 HOH A2453 HOH A2521 CRYST1 50.790 89.750 60.330 90.00 94.93 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019689 0.000000 0.001698 0.00000 SCALE2 0.000000 0.011142 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016637 0.00000